Results 261 to 270 of about 25,876,318 (284)
Some of the next articles are maybe not open access.
[Sodium-glucose co-transporter 2 inhibitor for diabetes?].
Nederlands tijdschrift voor geneeskunde, 2016Following initial expectations, raised by the results of the United Kingdom Prospective Diabetes Study, intervention studies aimed at tight glucose control did not reduce cardiovascular disease. The EMPA-REG OUTCOME, an empagliflozin intervention study in over 7,000 patients with type 2 diabetes mellitus and a history of cardiovascular disease, for the
openaire +1 more source
Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations
Anaesthesia, 2018P C A Kam
exaly

